There is a growing debate on whether people testing for omicron should swab their throats.
Most people in the U.S. have been doing COVID-19 rapid tests with nasal swabs. That is what the Food and Drug Administration endorses and what rapid tests sold in the U.S. instruct.a throat swab may be more effective at detecting omicron. Some are calling on the FDA and test manufacturers to better study throat swabs, saying that the reliance on nasal swabs may be one reason why rapid tests seem to be less sensitive in detecting omicron than previous variants.
Many consumers also are agitating, sometimes after finding that a throat swab yielded a positive test result when a nasal swab didn’t. On social media, the #swabyourthroat hashtag is gaining popularity. Some people are swabbing both their nose and throat in hopes of increasing their chances of getting an accurate result.last week to plead: "Please don’t go sticking that #COVID19 testing swab down your throat. Use swabs as instructed: via the nose.
A spokesman for Abbott Laboratories, which makes the BinaxNow at-home rapid tests, said, "We continue to monitor and evaluate. Our test is currently indicated for nasal use only." The idea that a person could swab their throat at home for a COVID-19 test isn’t totally out of left field. The
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Swab Nose, Throat, or Both for COVID-19 Rapid Tests?Rapid antigen tests for COVID-19 come with instructions to swab the nose only. Would adding a throat sample boost the accuracy? Learn more:
続きを読む »
How quickly do omicron symptoms appear? What’s the incubation period?Omicron symptoms can appear quicker than other variants of COVID-19.
続きを読む »
Avacta pauses sales of COVID-19 antigen test to boost Omicron sensitivityBritish biotech firm Avacta Group said on Monday it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron coronavirus variant at lower viral loads.
続きを読む »
Avacta pauses sales of COVID-19 antigen test to improve Omicron sensitivityBritain's Avacta Group is halting sales of its COVID-19 rapid antigen lateral flow test to replace antibodies in the device and boost its ability to detect the Omicron variant, the biotech firm said on Monday, sending its shares plunging nearly 27%.
続きを読む »
LA County Hits 2 Million COVID Cases, as Hospitalizations RiseLos Angeles County introduced a take-home program for COVID-19 test kits Monday as a way to expand testing during a rapid surge in infections.
続きを読む »
LA County launches take-home COVID-19 test program as way to expand testing during surgeLos Angeles County has introduced a take-home program for COVID-19 test kits as a way to expand testing during the rapid surge in infections.
続きを読む »